Public Health Regarding Medical Treatments

posted in: Domestic Policy, Policy Papers | 0

A proposal to improve efficacy, safety and cost-effectiveness of medical treatment in five ways: firstly, to publicly run all Phase III clinical trials, secondly to only approve drugs for treating a particular condition rather than for general sale, thirdly that NICE must consider a treatment cost-effective for each condition for it to be approved to treat that condition, fourthly to cap NHS drug prices at £20k/patient/QUALY, and finally to allow the NHS to produce combined medications. Updated in August 2011 in response to the impending move to value based pricing.

Download (PDF, 131KB)